Modeling Medication Adherence in Comparative Effectiveness Research

Comparative cost-effectiveness of interventions to improve medication adherence after myocardial infarction.

OBJECTIVE To evaluate the comparative cost-effectiveness of interventions to improve adherence to evidence-based medications among postmyocardial infarction (MI) patients. DATA SOURCES/STUDY SETTING Cost-effectiveness analysis. STUDY DESIGN We developed a Markov model simulating a hypothetical cohort of 65-year-old post-MI patients who were prescribed secondary prevention medications. We ev...

Comparative effectiveness--thinking beyond medication A versus medication B.

331 T American Recovery and Reinvestment Act of 2009 (ARRA), the stimulus package signed into law by President Barack Obama on February 17, 2009, directs $1.1 billion to support “the development and dissemination of research assessing the comparative effectiveness of health care treatments and strategies, including through efforts that . . . conduct, support, or synthesize research that compare...

Methods in comparative effectiveness research.

Comparative effectiveness research (CER) seeks to assist consumers, clinicians, purchasers, and policy makers to make informed decisions to improve health care at both the individual and population levels. CER includes evidence generation and evidence synthesis. Randomized controlled trials are central to CER because of the lack of selection bias, with the recent development of adaptive and pra...

Factors Associated with Medication Adherence in Coronary Artery Patients

Abstract: Introduction: Medication adherence plays an important role in preventing the worsening of cardiovascular disease. Some factors associated with medication adherence are still unknown. Objective: This study aimed to determine the factors related to medication adherence in patients with coronary artery disease. Materials and Methods: A cross-sectional analytical study was performed on...

CEPAC and comparative effectiveness research.